Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness. (Q47280810)
Jump to navigation
Jump to search
scientific article published in September 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness. |
scientific article published in September 2017 |
Statements
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness (English)
Thomas Re Barnes
Verity C Leeson
Carol Paton
Linda Davies
Raj Kumar
Patrick Keown
Rameez Zafar
Khalid Iqbal
Vineet Singh
Pavel Fridrich
Zachary Fitzgerald
Hemant Bagalkote
Peter M Haddad
Mariwan Husni